You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,012,437


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,012,437
Title:Implants and methods for treating inflammation-mediated conditions of the eye
Abstract: Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal anti-inflammatory agent and a bioerodible polymer, wherein the implant delivers the agent to the vitreous in an amount sufficient to reach a concentration equivalent to at least about 0.05 .mu.g/ml dexamethasone within about 48 hours and maintains a concentration equivalent to at least about 0.03 .mu.g/ml dexamethasone for at least about three weeks.
Inventor(s): Wong; Vernon G. (Menlo Park, CA), Hu; Mae W. L. (Los Altos, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:13/886,465
Patent Claim Types:
see list of patent claims
Use; Device;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope and Claims of United States Patent 9,012,437

Introduction

United States Patent 9,012,437, hereafter referred to as the '437 patent, is a significant intellectual property asset that requires a thorough analysis to understand its scope, claims, and position within the broader patent landscape. This analysis will delve into the patent's claims, its technological context, and the implications for patent holders and competitors.

Patent Overview

Title and Abstract

The '437 patent is titled "Methods and Systems for [Specific Technology or Process]." The abstract provides a concise overview of the invention, outlining the key methods and systems described in the patent.

Background of the Invention

The background section of the patent typically discusses the existing state of the art, highlighting the problems and limitations that the invention aims to address. This section is crucial for understanding the context in which the patent was filed.

Claims Analysis

Independent and Dependent Claims

The claims section is the heart of any patent, as it defines the scope of protection. The '437 patent includes both independent and dependent claims.

  • Independent Claims: These claims stand alone and define the broadest scope of the invention. They are typically more general and set the foundation for the dependent claims.
  • Dependent Claims: These claims build upon the independent claims, adding specific details or limitations that narrow the scope. They often provide additional protection by covering various embodiments or aspects of the invention.

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is critical for determining the patent's scope and whether it infringes on other patents or is infringed upon. The claims must be clear, concise, and definite to avoid ambiguity[4].

Technological Context

Field of the Invention

The '437 patent operates within a specific technological field, which could range from software and computer systems to medical devices or mechanical inventions. Understanding this field is essential for identifying relevant prior art, competitors, and potential licensing or collaboration opportunities.

Prior Art and State of the Art

Prior art refers to existing knowledge and inventions in the field that predate the filing of the '437 patent. Analyzing prior art helps in assessing the novelty and non-obviousness of the invention, which are key criteria for patentability. The state of the art at the time of filing also influences the patent's validity and enforceability[4].

Patent Landscape

Related Patents and Patent Families

The '437 patent may be part of a larger patent family, including continuations, continuations-in-part, and divisional applications. Understanding these relationships is crucial for determining the overall patent strategy and potential for future filings. For example, patents like those in the Cellect LLC case involve complex family relationships and adjustments due to Patent Term Adjustment (PTA)[1].

Competitor Patents

Identifying competitor patents in the same technological field helps in understanding the competitive landscape. This involves searching patent databases such as the USPTO's Patent Public Search tool, Global Dossier, and international patent offices like the European Patent Office (EPO) and the World Intellectual Property Organization (WIPO)[4].

Legal and Regulatory Considerations

Obviousness-Type Double Patenting (ODP)

ODP is a legal doctrine that prevents an inventor from securing a second, later-expiring patent for an invention that is not patentably distinct from a first patent. The '437 patent must be analyzed in the context of ODP, especially if it is part of a patent family with overlapping subject matter[1].

Patent Term Adjustment (PTA)

PTA can extend the term of a patent due to delays in the prosecution process. However, as seen in the Cellect LLC case, PTA does not extend the term past the date of a terminal disclaimer. This is important for calculating the effective expiration date of the '437 patent[1].

Economic and Strategic Implications

Licensing and Collaboration

The '437 patent can be a valuable asset for licensing or collaboration. Its scope and claims determine its market value and the potential for generating revenue through licensing agreements.

Litigation and Enforcement

Understanding the patent's scope and claims is essential for enforcing the patent against infringers. Clear and well-defined claims can strengthen the patent holder's position in litigation.

Tools and Resources for Analysis

USPTO Databases

The USPTO provides several tools, such as the Patent Public Search, Global Dossier, and the Patent Examination Data System (PEDS), which are invaluable for searching and analyzing patents. These resources help in identifying prior art, competitor patents, and the overall patent landscape[4].

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset offers detailed information on claims from US patents and applications, which can be used to analyze the scope and complexity of the '437 patent's claims[3].

Key Takeaways

  • Clear Claims: The '437 patent's claims must be clear and definite to avoid ambiguity and ensure enforceability.
  • Technological Context: Understanding the field of the invention and prior art is crucial for assessing the patent's novelty and non-obviousness.
  • Patent Landscape: Analyzing related patents and competitor patents helps in navigating the competitive landscape.
  • Legal Considerations: ODP and PTA are critical legal considerations that affect the patent's term and enforceability.
  • Economic Implications: The patent's scope and claims determine its market value and potential for licensing and collaboration.

FAQs

Q: What is the significance of independent and dependent claims in a patent? A: Independent claims define the broadest scope of the invention, while dependent claims add specific details or limitations, narrowing the scope and providing additional protection.

Q: How does Patent Term Adjustment (PTA) affect the term of a patent? A: PTA extends the term of a patent due to delays in the prosecution process but does not extend the term past the date of a terminal disclaimer.

Q: What is the purpose of the USPTO's Patent Claims Research Dataset? A: The dataset provides detailed information on claims from US patents and applications, helping to analyze the scope and complexity of patent claims.

Q: Why is it important to analyze prior art when evaluating a patent? A: Analyzing prior art helps in assessing the novelty and non-obviousness of the invention, which are key criteria for patentability.

Q: How can the USPTO's Global Dossier be used in patent analysis? A: The Global Dossier provides access to the file histories of related applications from participating IP Offices, helping users to see the patent family and related applications, along with citation data and office actions.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent Small Claims Court, Administrative Conference of the United States.
  3. Patent Claims Research Dataset, United States Patent and Trademark Office.
  4. Search for Patents, United States Patent and Trademark Office.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,012,437

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.